Net Deals Web Search

Search results

1. Results From The WOW.Com Content Network

2. Eli Lilly exec on weight-loss drugs: 'It's not just a flash ...

   www.aol.com/finance/eli-lilly-exec-weight-loss...

   June 10, 2024 at 2:32 PM. Eli Lilly stock jumps on weight-loss drug sales forecast. /. Loaded 0%. Eli Lilly ( LLY) is riding high on its diabetes and weight-loss treatments Mounjaro and Zepbound ...

3. FDA approves new version of diabetes drug Mounjaro for weight ...

   www.aol.com/fda-approves-version-diabetes-drug...

   This image provided by Eli Lilly on Wednesday, Nov. 8, 2023 shows packaging for their new drug Zepbound. The new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss ...

4. How the CFOs of Eli Lilly and Novo Nordisk are coping with ...

   www.aol.com/finance/cfos-eli-lilly-novo-nordisk...

   Indianapolis-based Eli Lilly (no. 142 on the Fortune 500) is the maker of Mounjaro, classified as Type 2 diabetes drug but which has led to weight loss among patients, and Zepbound, an obesity ...

5. Eli Lilly cracks down on the use of weight loss drugs ... - AOL

   www.aol.com/finance/eli-lilly-cracks-down-weight...

   Eli Lilly and Co. on Thursday warned against use of its popular diabetes and weight loss drugs Mounjaro and Zepbound for “cosmetic” reasons. The news comes as rampant demand for the reputed ...

6. US approves Lilly weight-loss drug, will compete with Novo's ...

   www.aol.com/news/us-fda-approves-lilly-weight...

   Eli Lilly shares have soared 67% in 2023 based on anticipation of approval of its drug for weight loss, making it the most valuable healthcare company on the S&P 500 index.

7. Lilly's Mounjaro leads to more and faster weight loss than ...

   www.aol.com/news/lillys-mounjaro-leads-more...

   Overweight or obese adults lost more weight and shed pounds faster using Eli Lilly's Mounjaro than those taking Novo Nordisk's popular rival weight loss drug, according to an analysis of health ...